Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1986;73:518-524

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Werns, S. W.
Right arrow Articles by Lucchesi, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Werns, S. W.
Right arrow Articles by Lucchesi, B. R.

Circulation, Vol 73, 518-524, Copyright © 1986 by American Heart Association


ARTICLES

Reduction of the size of infarction by allopurinol in the ischemic- reperfused canine heart

SW Werns, MJ Shea, SE Mitsos, RC Dysko, JC Fantone, MA Schork, GD Abrams, B Pitt and BR Lucchesi

This study was performed to assess the effect of allopurinol in a canine preparation of myocardial infarction. Dogs underwent occlusion of the left circumflex coronary artery for 90 min, followed by reperfusion for 6 hr. Three groups were studied: (1) control, (2) dogs receiving 25 mg/kg allopurinol 18 hr before occlusion and 50 mg/kg 5 min before occlusion, and (3) dogs receiving allopurinol as above plus 5 mg/kg superoxide dismutase over 1 hr beginning 15 min before reperfusion. Infarct size expressed as a percentage of the area at risk was 40 +/- 4 in the control group, 22 +/- 5 in the allopurinol group (p less than .05 vs control), and 17 +/- 4 in the allopurinol plus superoxide dismutase group (p less than .05 vs control). The differences in infarct size were not due to differences in myocardial oxygen supply or demand. Neutrophil superoxide anion production was not altered by allopurinol treatment. The results suggest that myocardial xanthine oxidase may generate oxygen radicals that play a role in myocardial injury due to ischemia and reperfusion.


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
P. Mladenka, R. Hrdina, Z. Bobrovova, V. Semecky, J. Vavrova, M. Holeckova, V. Palicka, Y. Mazurova, and P. Nachtigal
Cardiac biomarkers in a model of acute catecholamine cardiotoxicity
Human and Experimental Toxicology, October 1, 2009; 28(10): 631 - 640.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Jones, M. R. Hoffmeyer, B. R. Sharp, Y.-S. Ho, and D. J. Lefer
Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H277 - H282.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A. Belboul, D. Roberts, R. Borjesson, and J. Johnsson
Oxygen free radical generation in healthy blood donors and cardiac patients: the protective effect of allopurinol
Perfusion, January 1, 2001; 16(1): 59 - 65.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Wang, H. Chen, H. Qin, S. Sankarapandi, M. W. Becher, P. C. Wong, and J. L. Zweier
Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury
PNAS, April 14, 1998; 95(8): 4556 - 4560.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. S. Bayfield, J. R. Lindner, S. Kaul, S. Ismail, M. L. K. Sheil, N. C. Goodman, R. Zacour, and W. D. Spotnitz
DEOXYGENATED BLOOD MINIMIZES ADHERENCE OF SONICATED ALBUMIN MICROBUBBLES DURING CARDIOPLEGIC ARREST AND AFTER BLOOD REPERFUSION: EXPERIMENTAL AND CLINICAL OBSERVATIONS WITH MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY
J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1100 - 1108.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Xia, G. Khatchikian, and J. L. Zweier
Adenosine Deaminase Inhibition Prevents Free Radical-mediated Injury in the Postischemic Heart
J. Biol. Chem., April 26, 1996; 271(17): 10096 - 10102.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Zahger, J. Yano, A. Chaux, M. C. Fishbein, and W. Ganz
Absence of Lethal Reperfusion Injury After 3 Hours of Reperfusion : A Study in a Single-Canine-Heart Model of Ischemia-Reperfusion
Circulation, June 15, 1995; 91(12): 2989 - 2994.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
M. V. Cohen
Free Radicals in Ischemic and Reperfusion Myocardial Injury: Is this the Time for Clinical Trials?
Ann Intern Med, December 1, 1989; 111(11): 918 - 931.
[Abstract] [PDF]


Home page
CirculationHome page
G. K. Asimakis, S. Lick, and C. Patterson
Postischemic Recovery of Contractile Function is Impaired in SOD2+/- but Not SOD1+/- Mouse Hearts
Circulation, February 26, 2002; 105(8): 981 - 986.
[Abstract] [Full Text] [PDF]